S Dundas
S Dundas publishes mostly in Infectious Diseases, Epidemiology and Endocrinology, Diabetes and Metabolism, on topics such as COVID-19 Clinical Research Studies, Escherichia coli research studies and Clostridium difficile and Clostridium perfringens research.
- World rank
- #2,414,655 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #171,693 of 367,258
- Works
- 17
- Citations
- 491
- Citations per work
- 28.9
What does S Dundas research?
S Dundas's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1058.5%
- Medicine1058.5%
- Everything else635.2%
- Life Sciences16.3%
- 1Infectious Diseases27% of their works
- 2Epidemiology15% of their works
- 3Endocrinology, Diabetes and Metabolism6% of their works
- 4Endocrinology6% of their works
- 5Neurology6% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- COVID-19 Clinical Research Studies
- Escherichia coli research studies
- Clostridium difficile and Clostridium perfringens research
- Antibiotic Use and Resistance
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Which keywords describe S Dundas's research?
The keywords of their largest research topics: Epidemiology, ACE2 Receptor, SARS-CoV-2, Clinical Characteristics, Clinical Practice Guidelines, Thrombosis, Vaccine Development and Vaccine.
- spike protein
- Respiratory Syncytial Virus
- Norovirus
- Coronavirus
- Antimicrobial Stewardship
- Pathogenicity
- Escherichia coli
- Vaccine
- Thrombosis
- Clinical Characteristics
- ACE2 Receptor
- Epidemiology
- SARS-CoV-2
- Clinical Practice Guidelines
- Vaccine Development
- Antibiotic-Associated Diarrhea
- Fecal Microbiota Transplantation
- Antibiotic Resistance
- Community-Acquired Pneumonia
- Human Metapneumovirus
- Pneumococcal Conjugate Vaccine
- Rotavirus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Epidemiology166 topics
- ACE2 Receptor72 topics
- SARS-CoV-272 topics
- Clinical Characteristics51 topic
- Clinical Practice Guidelines52 topics
- Thrombosis51 topic
- Vaccine Development52 topics
- Vaccine42 topics
- Antibiotic-Associated Diarrhea31 topic
- Escherichia coli31 topic
- Fecal Microbiota Transplantation31 topic
- Pathogenicity31 topic
- Antibiotic Resistance21 topic
- Antimicrobial Stewardship21 topic
- Community-Acquired Pneumonia21 topic
- Coronavirus21 topic
- Human Metapneumovirus21 topic
- Norovirus21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Respiratory Syncytial Virus21 topic
- Rotavirus21 topic
- spike protein21 topic
Where does S Dundas work?
S Dundas's main affiliation in the publication record is Monklands Hospital, United Kingdom.
How many publications and citations does S Dundas have?
OpenAlex counts 17 works and 491 citations for S Dundas, an h-index of 9, ranking #2,414,655 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about S Dundas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.